FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046183929> ?p ?o ?g. }

• W2046183929 endingPage "267" @default.
• W2046183929 startingPage "258" @default.
• W2046183929 abstract "Objective clinical responses have been observed in approximately 50% of patients who received non-myeloablative chemotherapy prior to the adoptive transfer of autologous melanoma-reactive tumor-infiltrating lymphocytes (TILs). Recent studies carried out through the use of antibodies directed against T-cell-receptor beta chain variable region (TRBV) products, as well as by direct sequencing of the expressed TRBV gene products, indicated that clinical responses in this trial were associated with the level of persistence of adoptively transferred T cells. In an attempt to further characterize T cells that persist in vivo following adoptive transfer, five dominant T-cell clonotypes were identified in TIL 2035, an adoptively transferred TIL that was associated with the complete regression of multiple metastases. The most highly persistent clonotype, which expressed the BV1 TR gene product, recognized the MAGE-6 cancer/testis antigen in the context of HLA-A23. This clonotype was detected in peripheral blood for over 16 months following adoptive transfer, expressed relatively higher levels of the co-stimulatory markers CD28 and CD27, and possessed telomeres that were long relative to other clonotypes present in TIL 2035 that showed only short-term persistence. The long-term persistent BV1 clonotype appeared to differentiate more slowly toward an end-stage effector in vivo than short-term persistent clonotypes, as manifested by the downregulation of CD28, CD27, and CD45RO and upregulation of CD57 and CD45RA expression on these T cells. These results indicated that the differentiation stage and replicative history of individual TIL clonotypes might be associated with their ability to survive and to persist in vivo, and progressive differentiation of the persistent clonotypes occurred following adoptive transfer." @default.
• W2046183929 created "2016-06-24" @default.
• W2046183929 creator A5010039425 @default.
• W2046183929 creator A5014744153 @default.
• W2046183929 creator A5015880717 @default.
• W2046183929 creator A5051448151 @default.
• W2046183929 creator A5071013421 @default.
• W2046183929 creator A5072133376 @default.
• W2046183929 creator A5072313658 @default.
• W2046183929 date "2005-05-01" @default.
• W2046183929 modified "2023-10-18" @default.
• W2046183929 title "Survival, Persistence, and Progressive Differentiation of Adoptively Transferred Tumor-Reactive T Cells Associated with Tumor Regression" @default.
• W2046183929 cites W1575885906 @default.
• W2046183929 cites W1945834141 @default.
• W2046183929 cites W1967684158 @default.
• W2046183929 cites W1986512614 @default.
• W2046183929 cites W1994340919 @default.
• W2046183929 cites W2032253593 @default.
• W2046183929 cites W2034359690 @default.
• W2046183929 cites W2034530063 @default.
• W2046183929 cites W2042939784 @default.
• W2046183929 cites W2043114812 @default.
• W2046183929 cites W2047038388 @default.
• W2046183929 cites W2047125790 @default.
• W2046183929 cites W2050227969 @default.
• W2046183929 cites W2052260390 @default.
• W2046183929 cites W2064651531 @default.
• W2046183929 cites W2066145525 @default.
• W2046183929 cites W2075052419 @default.
• W2046183929 cites W2079228474 @default.
• W2046183929 cites W2096385955 @default.
• W2046183929 cites W2100433064 @default.
• W2046183929 cites W2115278843 @default.
• W2046183929 cites W2121976570 @default.
• W2046183929 cites W2122507780 @default.
• W2046183929 cites W2124573333 @default.
• W2046183929 cites W2126302947 @default.
• W2046183929 cites W2130374855 @default.
• W2046183929 cites W2133356144 @default.
• W2046183929 cites W2141824651 @default.
• W2046183929 cites W2144420689 @default.
• W2046183929 cites W2151246207 @default.
• W2046183929 cites W2158966732 @default.
• W2046183929 cites W2315098267 @default.
• W2046183929 doi "https://doi.org/10.1097/01.cji.0000158855.92792.7a" @default.
• W2046183929 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2174599" @default.
• W2046183929 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15838383" @default.
• W2046183929 hasPublicationYear "2005" @default.
• W2046183929 type Work @default.
• W2046183929 sameAs 2046183929 @default.
• W2046183929 citedByCount "171" @default.
• W2046183929 countsByYear W20461839292012 @default.
• W2046183929 countsByYear W20461839292013 @default.
• W2046183929 countsByYear W20461839292014 @default.
• W2046183929 countsByYear W20461839292015 @default.
• W2046183929 countsByYear W20461839292016 @default.
• W2046183929 countsByYear W20461839292017 @default.
• W2046183929 countsByYear W20461839292018 @default.
• W2046183929 countsByYear W20461839292019 @default.
• W2046183929 countsByYear W20461839292020 @default.
• W2046183929 countsByYear W20461839292021 @default.
• W2046183929 countsByYear W20461839292022 @default.
• W2046183929 countsByYear W20461839292023 @default.
• W2046183929 crossrefType "journal-article" @default.
• W2046183929 hasAuthorship W2046183929A5010039425 @default.
• W2046183929 hasAuthorship W2046183929A5014744153 @default.
• W2046183929 hasAuthorship W2046183929A5015880717 @default.
• W2046183929 hasAuthorship W2046183929A5051448151 @default.
• W2046183929 hasAuthorship W2046183929A5071013421 @default.
• W2046183929 hasAuthorship W2046183929A5072133376 @default.
• W2046183929 hasAuthorship W2046183929A5072313658 @default.
• W2046183929 hasBestOaLocation W20461839292 @default.
• W2046183929 hasConcept C147483822 @default.
• W2046183929 hasConcept C148125776 @default.
• W2046183929 hasConcept C151730666 @default.
• W2046183929 hasConcept C203014093 @default.
• W2046183929 hasConcept C2776090121 @default.
• W2046183929 hasConcept C2777701055 @default.
• W2046183929 hasConcept C2778326572 @default.
• W2046183929 hasConcept C2779343474 @default.
• W2046183929 hasConcept C502942594 @default.
• W2046183929 hasConcept C86803240 @default.
• W2046183929 hasConcept C8891405 @default.
• W2046183929 hasConcept C90375314 @default.
• W2046183929 hasConceptScore W2046183929C147483822 @default.
• W2046183929 hasConceptScore W2046183929C148125776 @default.
• W2046183929 hasConceptScore W2046183929C151730666 @default.
• W2046183929 hasConceptScore W2046183929C203014093 @default.
• W2046183929 hasConceptScore W2046183929C2776090121 @default.
• W2046183929 hasConceptScore W2046183929C2777701055 @default.
• W2046183929 hasConceptScore W2046183929C2778326572 @default.
• W2046183929 hasConceptScore W2046183929C2779343474 @default.
• W2046183929 hasConceptScore W2046183929C502942594 @default.
• W2046183929 hasConceptScore W2046183929C86803240 @default.
• W2046183929 hasConceptScore W2046183929C8891405 @default.
• W2046183929 hasConceptScore W2046183929C90375314 @default.
• W2046183929 hasIssue "3" @default.
• W2046183929 hasLocation W20461839291 @default.

• next